Pediatric radiation oncology requires a thoughtful integration of multi-modality care considerations into the radiation treatment paradigm.

Pediatric radiation oncology requires a thoughtful integration of multi-modality care considerations into the radiation treatment paradigm.

Pediatric radiation oncology requires a thoughtful integration of multi-modality care considerations into the radiation treatment paradigm.

Sarcomas are rare tumors. There are numerous ongoing advances in radiation therapy dosing and delivery for soft tissue sarcoma. Many physicians do not routinely see these tumors in practice because of their rarity.

This session will review the basic concepts of staging, overall treatment paradigm, radiation specific recommendations, radiation simulation, planning and treatment aspects, and literature regarding extremity and retroperitoneal soft tissue sarcomas.

In this session we will review current principles and data supporting the utilization of radiation therapy for patients with hematologic malignancies. We will explore current treatment paradigms as well as modern radiation treatment techniques that are utilized in this patient population.

This session aims to provide a comprehensive update on the latest advancements and evidence-based practices in the management of oligometastatic/oligoprogressive disease. It will include a didactic portion, case studies, and interactive discussions.

This refresher course will provide an overview of the treatment of prostate cancer with an emphasis on the role of radiation therapy in the treatment of localized disease, nodal disease, recurrent disease after prostatectomy and treatment of the primary in the setting of oligometastatic disease.

This session will focus on recent and emerging research in radiation oncology for patients with brain and spine tumors. Special emphasis will be placed on radiosurgery dose/fractionation selection, IDH inhibition in glioma and glioma contouring/targeting.

There have been many advances and evolutions in the treatment of primary and metastatic CNS tumors. There are different treatment planning and contouring guidelines for CNS tumors. Without a clear and consolidated understanding of best practices, this could affect quality of care.